Effectiveness of the Traditional Japanese Medicine Goshajinkigan in Preventing Paclitaxel-Induced Peripheral Neuropathy: A Multicenter Randomized Comparative Trial

化疗所致周围神经病变 医学 周围神经病变 中止 紫杉醇 随机对照试验 化疗 外围设备 内科学 多中心试验 多中心研究 肿瘤科 内分泌学 糖尿病
作者
Yukiko Matsumura,Masayuki Futagami,Tsukasa Baba,Shu Soeda,Hidemichi Watari,Yukihiro Terada,Hideki Tokunaga,Satoru Nagase,Toru Nakanishi,Kaiho Michiko,Yoshihito Yokoyama
出处
期刊:Integrative Cancer Therapies [SAGE Publishing]
卷期号:23: 15347354241278635-15347354241278635 被引量:10
标识
DOI:10.1177/15347354241278635
摘要

Objective: Development of chemotherapy-induced peripheral neuropathy (CIPN) poses significant challenges in cancer treatment, often leading to dose reductions or treatment discontinuation. Goshajinkigan (GJG), a traditional Japanese medicine, has shown promise for alleviating CIPN symptoms. This multicenter, randomized controlled trial aimed to prospectively examine the efficacy of GJG in preventing paclitaxel-induced peripheral neuropathy. Methods: This study enrolled 55 patients with ovarian cancer undergoing first-line chemotherapy using paclitaxel and carboplatin. The participants were randomized into Groups A (GJG initiation after onset of grade 2 neuropathy) and B (prophylactic administration of GJG from 1 week before chemotherapy). The primary endpoints were the proportion with a maximum sensory neuropathy grade and visual analog scale (VAS) scores. The secondary endpoints were the rate of chemotherapy completion and paclitaxel dose reduction due to neurotoxicity. Results: Prophylactic GJG administration (Group B) resulted in significant benefits. While both groups had a similar incidence of grade 2 sensory neuropathy, all patients in Group B with grade 2 neuropathy completed treatment without requiring additional analgesics. Group B exhibited lower VAS scores by the end of the study, reduced reliance on adjuvant analgesics (27.3% vs 66.7% in Group A), and significantly less frequent persistent CIPN 6 months post-chemotherapy (18.2% vs 55.6% in Group A). No differences were observed in the chemotherapy completion rates or CIPN-related changes between the groups. Conclusion: GJG, when administered prophylactically, showed potential for mitigating CIPN symptoms during paclitaxel chemotherapy. While promising, further research with placebo controls and objective measures is essential to comprehensively validate these findings.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
华无剑的应助被zhe采纳,获得10
刚刚
空集发布了新的文献求助10
1秒前
小蘑菇的应助被李建勋采纳,获得10
1秒前
1秒前
1秒前
核桃发布了新的文献求助10
1秒前
Dugarrygana发布了新的文献求助10
2秒前
cjzj完成签到,获得积分10
4秒前
CAOHOU的应助被XZM采纳,获得10
4秒前
GJoey发布了新的文献求助10
4秒前
6秒前
6秒前
放青松完成签到,获得积分10
8秒前
8秒前
CodeCraft的应助被空集采纳,获得10
8秒前
9秒前
junyang发布了新的文献求助10
9秒前
苗条梨愁发布了新的文献求助50
9秒前
RONGGE完成签到 ,获得积分10
9秒前
10秒前
renn发布了新的文献求助10
10秒前
haorandu发布了新的文献求助10
11秒前
11秒前
11秒前
852的应助被闫玉坤采纳,获得10
12秒前
牧百川发布了新的文献求助10
12秒前
kuakuapizza完成签到 ,获得积分10
12秒前
molihuakai的应助被野性的苗条采纳,获得10
13秒前
yyychenn发布了新的文献求助10
13秒前
cruise发布了新的文献求助10
13秒前
情怀的应助被lsq108采纳,获得10
13秒前
乾隆发布了新的文献求助10
13秒前
14秒前
Akim的应助被even采纳,获得10
14秒前
fzh完成签到 ,获得积分10
14秒前
D515发布了新的文献求助10
14秒前
蓝草完成签到,获得积分10
15秒前
冷酷向日葵完成签到,获得积分10
15秒前
心心发布了新的文献求助10
16秒前
Nole的应助被Ming采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183894
求助须知:如何正确求助?哪些是违规求助? 9573067
关于积分的说明 21829226
捐赠科研通 7780983
什么是DOI,文献DOI怎么找? 3434150
关于科研通互助平台的介绍 2558315
邀请新用户注册赠送积分活动 2480648